Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element

Molecular and Cellular Biology
Edward HittiMatthias Gaestel

Abstract

The mitogen-activated protein kinase (MAPK) p38/MAPK-activated protein kinase 2 (MK2) signaling pathway plays an important role in the posttranscriptional regulation of tumor necrosis factor (TNF), which is dependent on the adenine/uridine-rich element (ARE) in the 3' untranslated region of TNF mRNA. After lipopolysaccharide (LPS) stimulation, MK2-deficient macrophages show a 90% reduction in TNF production compared to the wild type. Tristetraprolin (TTP), a protein induced by LPS, binds ARE and destabilizes TNF mRNA. Accordingly, macrophages lacking TTP produce large amounts of TNF. Here, we generated MK2/TTP double knockout mice and show that, after LPS stimulation, bone marrow-derived macrophages produce TNF mRNA and protein levels comparable to those of TTP knockout cells, indicating that in the regulation of TNF biosynthesis TTP is genetically downstream of MK2. In addition, we show that MK2 is essential for the stabilization of TTP mRNA, and phosphorylation by MK2 leads to increased TTP protein stability but reduced ARE affinity. These data suggest that MK2 inhibits the mRNA destabilizing activity of TTP and, in parallel, codegradation of TTP together, with the target mRNA resulting in increased cellular levels of TTP.

References

May 15, 1994·Analytical Biochemistry·J O KarlssonM Andersson
Apr 16, 1999·Science·G LaroiaR J Schneider
Nov 13, 1999·Nature Cell Biology·A KotlyarovM Gaestel
Jul 4, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·W ZhuJ Han
Feb 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Gaurav LaroiaRobert J Schneider
Jun 8, 2002·Molecular and Cellular Biology·Alexey KotlyarovMatthias Gaestel
Nov 21, 2002·Biochemical Society Transactions·P J Blackshear
Nov 21, 2002·Biochemical Society Transactions·N Kedersha, P Anderson
Jan 10, 2003·Nucleic Acids Research·Tala BakheetKhalid S A Khabar
Feb 5, 2003·Biochemical and Biophysical Research Communications·Frank BolligHelmut Holtmann
Nov 1, 2003·Biochemical Society Symposium·Jeremy SaklatvalaAndrew Clark
Dec 23, 2003·The Journal of Biological Chemistry·Carol A ChrestensenThomas W Sturgill
Jan 9, 2004·The Journal of Biological Chemistry·Jin-Yu Lu, Robert J Schneider
Mar 11, 2004·The Journal of Biological Chemistry·Heping CaoPerry J Blackshear
Jun 10, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Seth A BrooksWilliam F C Rigby
Jul 15, 2004·Current Opinion in Pharmacology·Jeremy Saklatvala
Nov 13, 2004·Arthritis Research & Therapy·Danielle M CarrickPerry J Blackshear
Mar 22, 2005·Molecular Pharmacology·Marcel FechirHartmut Kleinert

❮ Previous
Next ❯

Citations

May 25, 2010·Cellular and Molecular Life Sciences : CMLS·Khalid S A Khabar
Dec 12, 2007·The Protein Journal·Heping Cao, Rui Lin
Mar 26, 2013·Journal of Neuro-oncology·Esther A SuswamPeter H King
Feb 14, 2009·Immunologic Research·Jim MillerTakeshi Yoshida
Mar 7, 2012·Nature Reviews. Genetics·Daniel R Schoenberg, Lynne E Maquat
Jun 27, 2006·Nature Reviews. Immunology·Jonathan D Ashwell
May 15, 2007·Oncogene·A G TurjanskiJ S Gutkind
Mar 13, 2008·Médecine sciences : M/S·Mai Nguyen-Chi, Dominique Morello
Oct 5, 2011·Proceedings of the National Academy of Sciences of the United States of America·Murugesan V S RajaramLarry S Schlesinger
Aug 6, 2009·The Journal of Biological Chemistry·Yvonne M SchichlRainer de Martin
Jul 3, 2010·The Journal of Biological Chemistry·Francesco P MarcheseJonathan L E Dean
Apr 22, 2011·The Journal of Biological Chemistry·Won Hyeok LeeJeong Woo Park
Jan 30, 2009·The Journal of Biological Chemistry·Aurélien LauwersCyril Gueydan
Mar 5, 2009·The Journal of Biological Chemistry·Rachel L OgilviePaul R Bohjanen
Feb 5, 2011·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Weiguo YinXiaoxia Li
Aug 25, 2012·Molecular Biology of the Cell·Michael FählingRalf Mrowka
Oct 8, 2009·Carcinogenesis·Claus JohansenLars Iversen
Feb 26, 2008·Journal of Biochemistry·Kayoko KawaiHiroyuki Osada
May 11, 2010·Cold Spring Harbor Perspectives in Biology·Ranjan Sen, Stephen T Smale
Dec 9, 2010·The Journal of Pharmacology and Experimental Therapeutics·Qiyan LiKeith L Kirkwood
Oct 7, 2009·Pharmacological Reviews·Xiaomin DengRobert A Roth
Nov 17, 2010·Molecular and Cellular Biology·Sandra L ClementJens Lykke-Andersen
Feb 6, 2013·Molecular and Cellular Biology·Kirsty F MacKenzieJ Simon C Arthur
Mar 5, 2011·Microbiology and Molecular Biology Reviews : MMBR·Marie Cargnello, Philippe P Roux
Oct 14, 2006·Annals of the Rheumatic Diseases·S E Sweeney, G S Firestein
Aug 13, 2009·Journal of Biomedicine & Biotechnology·Maria BaouJohn J Murphy
Sep 20, 2012·International Journal of Inflammation·Nhat-Tu LeJun-Ichi Abe
Jul 11, 2009·Pharmacology·Barry L BurnetteJoseph Monahan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.